Post Market Clinical FoIIow up (PMCF) Medical Device (MD) of Z-Systems Monotype Zirconia Dental Product: Z5m Dental Implants Registry
Launched by Z-SYSTEMS · Aug 17, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new type of dental implant made from zirconia, a ceramic material, to see how well it works for people missing teeth. Zirconia implants are being explored because they offer a metal-free option that some patients prefer, especially those with metal sensitivities or those seeking a more natural look in their smile. The trial is designed as a registry, which means it will track the experiences of patients receiving these implants in real-world settings to gather information on their long-term benefits and risks.
To participate in this study, you must be an adult (18 years or older) who is receiving up to five Z-Systems Z5m zirconia implants and have signed an informed consent form. If you decide to join, you can expect to have your progress monitored over time, helping to provide valuable insights into the performance of zirconia implants. This trial is open to all genders and is currently recruiting participants, making it an exciting opportunity for those who might benefit from this innovative dental solution.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patient (≥ 18 years) was or will be implanted with up to 5 implants of the Z-Systems Z5m product group
- • Patient has signed Informed Consent.
- Exclusion Criteria:
- • • Inability to give consent
About Z Systems
Z-Systems is a pioneering clinical trial sponsor dedicated to advancing healthcare through innovative research and development. Specializing in the design and management of clinical trials, Z-Systems leverages cutting-edge technology and a robust network of clinical sites to facilitate the efficient evaluation of new therapies across various therapeutic areas. Committed to ensuring the highest standards of quality and compliance, Z-Systems collaborates closely with regulatory bodies, healthcare professionals, and patients to drive scientific discovery and improve patient outcomes. With a focus on transparency and integrity, Z-Systems strives to accelerate the delivery of safe and effective treatments to the market.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Olten, , Switzerland
Patients applied
AH
PS
ST
AC
CW
DP
TN
AG
LP
Trial Officials
Mariane Sordi, PhD
Study Director
Z-Systems
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported